Jump to content

Page values for "Insulin Aspart"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringInsulin aspart
brandStringNovoLog, Fiasp (ultra-rapid), Trurapi
structureFile
classesList of String, delimiter: ,[[:Category:Insulins|Insulin]] [[:Category:Rapid-acting_insulins|Rapid-acting insulin analog]] [[:Category:Mealtime_insulins|Mealtime (bolus) insulin]]
mechanismString
usesString'"`UNIQ--vote-000005EF-QINU`"', '"`UNIQ--vote-000005F0-QINU`"', '"`UNIQ--vote-000005F1-QINU`"'
starting_doseStringSC 4-6 units (or 1 unit per 10-15 g carbs) at meals; titrate to postprandial glucose
preparationsString100 U/mL (NovoLog, Fiasp) vials, pens, cartridges
fda_maxStringTitrated to glucose; no fixed maximum
pill_idText
routesList of String, delimiter: ,Subcutaneous IV insulin pumps
onsetStringSC: 5-15 minutes (Fiasp 2.5 minutes earlier on average)
durationString3-5 hours
halflifeString~80 minutes SC'"`UNIQ--ref-000005F2-QINU`"'
bioavailabilityString~100% from subcutaneous depot
pregnancyStringInsulin is the preferred glucose-lowering therapy in pregnancy; aspart is widely used.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US